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Photo- and pH-Triggered Release of Anticancer Drugs  
from Mesoporous Silica-Coated Pd@Ag NanoparticlesA smart drug delivery system integrating both photothermal therapy and 
chemotherapy for killing cancer cells is reported. The delivery system is based 
on a mesoporous silica-coated Pd@Ag nanoplates composite. The Pd@Ag 
nanoplate core can effectively absorb and convert near infrared (NIR) light 
into heat. The mesoporous silica shell is provided as the host for loading 
anticancer drug, doxorubicin (DOX). The mesoporous shell consists of large 
pores, ∼10 nm in diameter, and allows the DOX loading as high as 49% in 
weight. DOX loaded core–shell nanoparticles exhibit a higher efficiency in 
killing cancer cells than free DOX. More importantly, DOX molecules are 
loaded in the mesopores shell through coordination bonds that are respon-
sive to pH and heat. The release of DOX from the core-shell delivery vehicles 
into cancer cells can be therefore triggered by the pH drop caused by endo-
cytosis and also NIR irradiation. A synergistic effect of combining chemo-
therapy and photothermal therapy is observed in our core-shell drug delivery 
system. The cell-killing efficacy by DOX-loaded core–shell particles under NIR 
irradiation is higher than the sum of chemotherapy by DOX-loaded particles 
and photothermal therapy by core–shell particles without DOX.1. Introduction
Drug delivery with controllable release using nanoscale car-
riers is a very important research area in biomedical sciences.[1]  
Polymer-based carriers have been used as smart drug delivery sys-
tems for decades, and some polymer carriers have been approved 
for human clinical use by the U.S. Food and Drug Administra-
tion.[2] Due to their possible enhanced stability in biological sys-
tems, inorganic-based vectors used for biomedical applications 
have attracted increasing research attention in the past years.
Among inorganic-based materials, mesoporous silica nanopar-
ticles (MSNs) are advantagenous in the area of drug controllable 
release in that they display excellent stability, non-cytotoxicity, 
tunable porosity and facile modification.[3] To apply MSNs as 
effective carriers for drug controllable release, various strate-
gies have been developed by introducing labile chemical bonds wileyonlinelibrary.com © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhe
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and interactions can respond to external 
agents and conditions, such as salt concen-
tration,[4] pH,[5] temperature,[6] enzyme/
DNA,[7] reducing biomolecules,[8] light[9] 
and so on. Among them, light-responsive 
controlled release is a very important 
method because of the non-invasive nature 
and high spatial resolution of light. For 
instance, the release of guest molecules in 
MCM-41 nanoparticles could be triggered 
by UV irradiation using coumarin dimers 
as the photo-cleavable molecular gates.[10] 
A similar control strategy was achieved by 
modifying the pores of MSNs with azoben-
zene derivatives which could undergo 
cis–trans isomerization under laser irradia-
tion at 412 nm.[11] The other approach is to 
use polymers or gold nanoparticles to block 
the pores of MSNs.[12] Under ultraviolet–
visible (UV–vis) light irradiation, the pores 
could be opened to release the drug mole-
cules loaded inside the mesopores. Owing to its low penetrability and harm to tissue, however, ultraviolet/
visible light for drug controllable release has received limited 
use in in vivo applications. In comparison with UV–vis light, 
near-infrared (NIR) light can deeply penetrate tissues.[13] To con-
trol the drug release using NIR, several groups have modified 
MSNs by attaching drug molecules or nanoparticles through 
NIR light sensitive covalent bonding.[14]
Based on mesoporous silica-coated Pd@Ag nanoplates, 
we now report a smart drug delivery system integrating both 
photothermal therapy and chemotherapy for killing cancer 
cells. While the Pd@Ag nanoplate core can effectively absorb 
and convert NIR light into heat, the mesoporous silica shell 
is provided as the host for loading anticancer drug, doxoru-
bicin (DOX). Three important features are associated with our 
delivery system: 1) Unlike many reported Au/Ag nanostruc-
tures that could melt themselves into spheres upon NIR irra-
diation, the Pd@Ag nanoplates that are used as the core in 
our system exhibit excellent photothermal stability.[15,16] 2) The 
mesoporous shell consists of large pores, ∼10 nm in diameter. 
The enlarged pore offers significantly improved drug loading 
capacity. The DOX loading in our delivery vehicles is as high 
as 49% in weight. 3) DOX molecules are loaded in the mes-
oporous shell through coordination bonds that are responsive 
to pH and heat. In physiological pH (∼7.4), DOX molecules are 
barely released from the vehicles. But the DOX release can be 








Scheme 1. Synthetic Process of Pd@Ag@sSiO2@mSiO2-DihBen/DOX 
Nanocomposites.
Figure 1. SEM (a,b) and TEM (c,d) images of Pd@Ag@sSiO2 and Pd@
Ag@sSiO2 @mSiO2 nanoparticles.
Figure 2. N2 adsorption/desorption isotherm and the pore size distribu-
tion (inset) of Pd@Ag@sSiO2@mSiO2 nanoparticles.












































when the particles are endocytosed by cancer cells. With the 
incorporation of the Pd@Ag photothermal core in the delivery 
system, the release of DOX can also be triggered by NIR irra-
diation. Our in vitro experiments reveal a synergistic effect 
that the cell-killing efficacy by DOX-loaded core-shell particles 
under NIR irradiation is even higher than the sum of chemo-
therapy by DOX-loaded particles and photothermal therapy by 
core-shell particles without DOX.
2. Results and Discussion
Scheme 1 shows the procedure for the synthesis of mesoporous 
silica-coated Pd@Ag nanoparticles. The Pd@Ag nanoplates 
with a mean diameter of 41 nm and a Ag/Pd ratio of 2.1 were 
first prepared according to our recently reported method.[16] 
Compared with Ag/Au nanoplates, these Pd@Ag nanoplates 
exhibit significantly enhanced photothermal stability under NIR 
irradiation. Before coating the Pd@Ag nanoplates with mesopo-
rous silica, a layer of dense silica was grown on the nanoplates 
using a modified Stöber method (see the Experimental Section 
for details). As shown in Figure 1 (and Figure S1 in the Sup-
porting Information), the obtained Pd@Ag@sSiO2 particles 
were oblate spheroids with an average diameter of 110 nm and 
a thickness of 60 nm. A mesoporous silica was then deposited 
on Pd@Ag@sSiO2 particles using a modified method reported 
by Tatsumi et al.[17] In our synthesis, the amount of l-Arginine 
(Arg) was reduced to decrease the rate of reaction and trimeth-
ylbenzene (TMB) was introduced as a swelling agent for the 
CTAC micelles to enlarge the pores. The growth of mesoporous 
silica around the Pd@Ag@sSiO2 core was also evidenced by 
both SEM and TEM analysis. The formation of the mesoporous 
silica shell should consist two main steps:[18] 1) The CTAC micelles 
were firstly adsorbed on the surface of Pd@Ag@sSiO2 particles 
by electrostatic interaction. 2) Silica was then co-assembled 
with CTCA to form the mesostructure under weakly basic 
conditions. The as-prepared Pd@Ag@sSiO2@mSiO2 particles © 2012 WILEY-VCH Verlag GAdv. Funct. Mater. 2012, 22, 842–848had an average diameter of ∼150 nm. The pores in the mes-
oporous shells were ∼10 nm, much larger than the typical 
pores in MCM-41 made in the absence of swelling agent. The 
enlarged pores were also confirmed by our N2 adsorption–
desorption experiments (Figure 2). The isotherm of Pd@Ag@
sSiO2@mSiO2 after CTAC extraction shows a typical type IV 
feature. The BET (Brunauer–Emmett–Teller) surface area and 
pore volume of the core–shell nanoparticles were measured 
to be 489 m2 g−1 and 0.972 m3 g−1, respectively. The average 
pore diameter was calculated to be 10 nm from the desorption 
branch of the isotherm by using the Barrett–Joyner–Halenda 
(BJH) model.
After the creation of the mesoporous shell, CTAC mole-
cules in the pore were removed by an ion-exchange method. 
As shown in the infrared spectra of CTAC, Pd@Ag@sSiO2@










Figure 3. IR spectra of CTAC (top curve), Pd@Ag@sSiO2@mSiO2/CTAC 
(middle curve) and Pd@Ag@sSiO2@mSiO2 (bottom curve).













Pd@Ag@m-SiO2strong absorption bands around 2920 cm−1 and 2849 cm−1 were 
assigned the stretching of the C–H bonds of the CTAC mol-
ecules. After ion exchange with NH4NO3, the strong absorption 
bands disappeared, suggesting that the CTAC molecules had 
been removed successfully. The particles were then modified 
with amino groups by reacting with 3-aminopropyltriethoxysi-
lane (APTES) (see the Experimental Section for details). These 
amino-bearing particles were reacted with 3,4-dihydroxyben-
zaldehyde (DihBen) to yield Pd@Ag@sSiO2@mSiO2-DihBen 
particles. As shown in Figure 4, the apparent absorption bands 
around at 1380 cm−1, 1465 cm−1 and 2953 cm−1, which were 
assigned to aromatic C-C (arC–C) and C–H bonds respectively, 
suggested that the DihBen motifs were successfully anchored wileyonlinelibrary.com © 2012 WILEY-VCH Verlag Gm
Figure 4. IR spectra of 3,4-dihydroxybenzaldehyde (top curve), Pd@
Ag@sSiO2@mSiO2 (middle curve) and Pd@Ag@sSiO2@mSiO2-DihBen 
(bottom curve).














Pd@Ag@mSiO2-Dibenonto the Pd@Ag@sSiO2@mSiO2 particles. Subsequently, Fe3+ 
ions were bound to the dihydroxybenzene motifs. Finally, DOX 
molecules were loaded onto the pore walls through –NH2–Fe3+ 
coordination.[19] The loading of DOX on the Fe3+-immobilized 
particles was evaluated by monitoring the fluorescence of the 
DOX solutions treated with the core–shell nanoparticles. After 
loaded on the particles, the fluorescence of DOX was quenched, 
which was also previously observed when they were loaded 
on other nanocarriers.[20] Based on the change of fluorescence 
intensity (Figure 5a), the loading of DOX on Pd@Ag@sSiO2@
mSiO2-DihBen-Fe3+ was calculated as high as 49 wt% related 
to the weight of core–shell mesoporous carriers.[20b] Such a 
high DOX loading has not been reported for MSNs. In com-
parison, the adsorption amount of DOX for pure Pd@Ag nano-
plates and Pd@Ag@sSiO2 nanoparticles was only 1.9 wt% and 
3.9 wt%, respectively. It is believed that the enhanced DOX 
loading capacity of Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ is due 
to the enlarged mesopores in favor of DOX, which are rather 
large drug molecules (1.53 nm × 1.19 nm).
DOX molecules are bound to the Pd@Ag@sSiO2@mSiO2-
DihBen-Fe3+ particles through -NH2-Fe3+ coordination bonds. 
Considering that –NH2–Fe3+ bonds are fairly stable under neu-
tral condition but prone to be attacked by acids, one would expect 
a pH-controllable release of DOX loaded on Pd@Ag@sSiO2@
mSiO2-DihBen-Fe3+. Indeed, as clearly shown in Figure 5b, 
both the amount and the rate of DOX release in PBS buffers 
highly depend on the pH values. Within 8 h, only 7.2% of the 
DOX adsorbed on the particles was released. Lowering the pH 
to 6.0, 5.0, and 4.0 increased the DOX release to 17%, 26%, and 
36%, respectively.
As described above, one key feature of our core-shell delivery 
system lies in the Pd@Ag nanoplate core that can effectively 
absorb and convert NIR light into heat. As shown in Figure 5c, 
even after silica coating, the strong NIR absorption feature of 
Pd@Ag nanoplates was nicely kept although the absorption 
peak became slightly broader. Under laser irradiation of 1 W at 
808 nm, the temperature of 1 mL solution containing 200 ppm 
(weight of all components) Pd@Ag@sSiO2@mSiO2-DihBen-
Fe3+ nanoparticles was raised from 27.1 to 51.7 °C (Figure 5d). 
The bond strength of coordination typically decreases with tem-
perature. Therefore, a temperature increase resulted from the 
photothermal effect by the Pd@Ag core would help to release 
more DOX molecules from Pd@Ag@sSiO2@mSiO2-DihBen-
Fe3+ nanoparticles. Indeed, a significant promotion effect of 
NIR irradiation on the DOX release was observed experimen-
tally (Figure 6). At pH 4, irradiation with a 1 W, 808 nm NIR 
laser increased the DOX release up to 63.2% within 1 h. In 
comparison, only 33.5% DOX was released without the irra-
diation. At pH 7.4, an increase of 1 h DOX release from 3.8 to 
9.6% was also achieved by NIR irradiation. These results verify 
that the core–shell mesoporous nanoparticles have successfully 
achieved the drug controllable release by pH and NIR light.
The success in controlling the DOX release by both pH 
and NIR laser motivated us to examine whether the delivery 
system would work in living cells. We first examined the bio-
compatibility of the Pd@Ag@sSiO2@mSiO2-DihBen particles 
by incubating Hep-G2 cells with the nanoparticles at different 
concentrations for 24 h. As revealed by the 3-(4,5-dimethylthia-














































































Figure 5. a) Fluorescence spectra showing the change of emission intensity of the solutions of DOX before and after treated with Pd@Ag@sSiO2@
mSiO2-DihBen-Fe3+ nanoparticles. b) Release kinetics of DOX from Pd@Ag@sSiO2@mSiO2 in PBS buffer at different pH values. c) UV–vis spectra of 
Pd, Pd@Ag and Pd@Ag@sSiO2@mSiO2 nanoparticles in water solution. d) Temperature versus time plots of 1 mL solutions containing Pd@Ag@
sSiO2@mSiO2-DihBen-Fe3+ nanoparticles in various concentrations under laser irradiation of 1 W at 808 nm.viability of the cells was only reduced by ∼20% after 24 h NIR 
exposure to a Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ dispersion 
containing 200 ppm particles (Figure 7a). Based on these cyto-
toxicity data, we have limited the amount of Pd@Ag @sSiO2@
mSiO2-DihBen in our cell studies to less than 200 ppm.
In contrast to DOX loaded on Pd@Ag@sSiO2@mSiO2-
DihBen-Fe3+, free DOX molecules are highly fluorescent, 
allowing us to use fluorescence microscopy to monitor the drug 
release inside living cells. Before fluorescence microscopy was 
performed, Hep-G2 cells were first incubated with DOX loaded 
nanoparticles (20 ppm DOX) for 4 h and then washed with 
PBS. As clearly revealed by fluorescence microscopy images © 2012 WILEY-VCH Verlag GmAdv. Funct. Mater. 2012, 22, 842–848(Figure S2 in the Supporting Information), intense fluorescence 
signals were observed inside the cells. Since the fluorescence of 
DOX was significantly quenched when loaded on the particles, 
the appearance of fluorescence signals inside the cells indicated 
the actual release of DOX from the Pd@Ag@sSiO2@mSiO2-
DihBen-Fe3+. It should be noted that the fluorescence signals 
inside the cells incubated with the same concentration of free 
DOX for 4 h were much weaker (Figure S2). This result indi-
cates that the Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ particles 
help the DOX delivery into Hep-G2 cells.
With no doubt, the improved DOX delivery efficacy by Pd@









Figure 6. Release kinetics of DOX from Pd@Ag@sSiO2@mSiO2 in PBS 
buffer at pH values of 7.4 and 4.0 with or without laser irradiation at 808 nm.






















Figure 7. a) Viability of Hep-G2 cells incubated for 24 h with different con-
centrations of Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ particles. b) Hep-G2 
cell viabilities after a 10 h incubation with different concentrations of free 
DOX, Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ (MSNs) and DOX-loaded 
Pd@Ag@ sSiO2@mSiO2-DihBen-Fe3+ with or without 5-min NIR irradia-
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cell killing activity of the drug. To confirm such an argument, 
Hep-G2 cells were incubated with free DOX and DOX-loaded 
core-shell nanoparticles at different concentrations for 10 h. The 
MTT assay was then carried out to test cell viabilities. The DOX-
loaded core-shell nanoparticles exhibited higher cytotoxicity 
than free DOX at the same concentrations. While 50 ppm free 
DOX killed only 36% cells, the same amount of DOX loaded on 
Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ particles killed 62% cells 
(Figure 7b, S3). This result can be explained by that DOX-loaded 
nanoparticles can enter cancer cells more easily than free DOX 
probably through endocytosis mechanism. Once taken up by 
living cells, the particles experience a pH drop to ∼5.5 or even 
lower to trigger the release of DOX from the particles.
We have also investigated the feasibility to use NIR laser radi-
ation to enhance the cell-killing efficacy of DOX-loaded Pd@
Ag@sSiO2@mSiO2-DihBen-Fe3+ particles. In these studies, 
Hep-G2 cells were first incubated with DOX-loaded nanopar-
ticles for 8 h. After the culture media was replaced by fresh 
media, the cells were subjected to the NIR irradiation (808 nm, 
1 W) for 5 min. After irradiation, the cells were further incu-
bated for 2 h before cell viabilities were determined by MTT. 
With the NIR irradiation, more cells were killed by DOX-loaded 
particles at all tested concentrations (Figure 7b and Figure S4 
in the Supporting Information). For instance, when exposed to 
NIR laser, 77% of the cells were killed at the DOX concentra-
tion of 20 ppm. In comparison, 46% of the cells were killed in 
the presence of DOX-loaded particles but the absence of NIR 
irradiation. In the absence of DOX, Pd@Ag@sSiO2@mSiO2-
DihBen-Fe3+ under 5-min NIR irradiation killed only 15% of the 
cells. The cell-killing efficacy by DOX-loaded Pd@Ag@sSiO2@
mSiO2-DihBen-Fe3+ core–shell particles under NIR irradiation 
was even higher than the sum of chemotherapy by DOX-loaded 
Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ particles and photo-
thermal therapy by unloaded Pd@Ag@sSiO2@mSiO2-DihBen-
Fe3+ particles. This result demonstrates the synergistic effect 
of combining photothermal therapy and chemotherapy in our 
core-shell drug delivery system.846 wileyonlinelibrary.com © 2012 WILEY-VCH Verlag G3. Conclusions
In summary, a smart anticancer drug delivery system based on 
Pd@Ag@sSiO2@mSiO2 core–shell particles has been devel-
oped. The core–shell architecture allows to integrate the photo-
thermal component (Pd@Ag nanoplates), that can convert NIR 
light to heat, with the high-surface area component (mesopo-
rous SiO2 shell) for the loading of anticancer drug molecules 
(DOX). Through coordination bonds that are responsive to pH 
and heat, the release of DOX from the core–shell particles can 
be triggered by pH and NIR light, resulting in a synergistic 
effect for cancer cell killing.
4. Experimental Section
Materials: DOX was purchased from HuaFeng United Technology 
Co. Ltd. (Beijing, China). Pd(acac)2, tetraethoxysilane (TEOS), 
3-aminopropyltrimethoxysilane (APTES) and mesitylene were purchased 
from Alfa Aesar. 3,4-dihydroxybenzaldehyde, Arg (l-arginine) and CTAC 







www.MaterialsViews.comChemical Reagent Co. Ltd. (Shanghai, China). Hep-G2 cells were 
purchased from cell storeroom of Chinese Academy of Sciences. All 
reagents were used as received without further purification.
Synthesis of Pd@Ag: Pd and Pd@Ag nanosheets were prepared 
according to our recently reported method.[16] In brief, the obtained 
palladium nanosheets (5.79 mg, 4.0 mL solution) were purified by an 
ethanol-acetone mixture solution, and then dispersed in 45.5 mL of ultra-
pure water containing 20 mg of AgNO3. After stirred for several minutes, 
2.5 mL of formaldehyde solution (40%) was added to the above mixture. 
The mixture was allowed to react for 8 h at statically to give rise to an 
ultramarine solution. The resulting solution was stored at 4 °C for future 
use.
Synthesis of Pd@Ag@sSiO2: 16.0 mL of the above solution containing 
6.17 mg of Pd@Ag was mixed with 128 mL of ethanol. 320 μL of TEOS 
was then added to the mixture, followed by 2.0 mL of methylamine 
aqueous solution (40%). After reacted for 10 h at room temperature, the 
product was purified by centrifuging at 14500 rpm for 12 min, washed, 
and re-dispersed in ethanol.
Synthesis of Pd@Ag@sSiO2@mSiO2: The product was synthesized 
using a modification of the literature method for the synthesis of 
mesoporous silica.[17] The above Pd@Ag@sSiO2 nanoparticles were 
re-dispersed in 120 mL of ultrapure water containing 480 mg of CTAC 
and 1.2 mL of mesitylene. After ultrasonication for 30 min, 160 μL of 
TEOS was added, followed by 24.0 mg of Arg (l-arginine) in 1.0 mL of 
water. The reaction solution was stirred for 24 h at 45 °C before the 
products were collected by centrifugation, washed with ethanol-water 
mixed solution and then dispersed in 60 mL of ethanol containing 1.2 g 
of NH4NO3. Finally, the mixture was heated to 45 °C under stirring for 
6 h in order to remove surfactant template, the procedures were repeated 
for three times.
Preparation of Pd@Ag@sSiO2@mSiO2-NH2: 30.0 mg Pd@Ag@
sSiO2@mSiO2 nanoparticles, 60.0 mL ethanol, 60.0 μL water and 
30.0 μL 3-aminopropyltrimethoxysilane (APTES) were mixed and heated 
to 45 °C overnight. The product was separated by centrifugation, washed 
with ethanol and finally re-dispersed in ethanol for subsequent use.
Preparation of Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+: Pd@Ag@sSiO2@
mSiO2-NH2 nanoparticles (4.0 mg) were dispersed in 2.0 mL of ethanol. 
After that, 0.1 mg of 3, 4-dihydroxybenzaldehyde in ethanol solution 
was added under stirring. After stirring for 4 h at room temperature, 
the product was collected by centrifugation and washed with ethanol for 
one time. The 3,4-dihydroxybenzaldehyde modified Pd@Ag@sSiO2@
mSiO2-NH2 nanoparticles were then re-dispersed in ethanol, followed by 
adding 120 μL of 0.05 m Fe(NO3)3·9H2O ethanol solution. The mixture 
solution was stirred overnight. Finally, the particles were centrifuged, 
washed for three times with ethanol and then dispersed in PBS for 
subsequent use.
DOX Loading and Release Studies: 2.0 mg of Pd@Ag@sSiO2@mSiO2-
DihBen-Fe3+ nanoparticles were mixed with 1.2 mg of DOX in 1.0 mL of 
PBS (pH = 7.4), and stirred at room temperature for 36 h. The mixture 
was centrifuged and washed for three times with PBS (pH = 7.4). To 
measure the amount of DOX loaded in the core-shell mesoporous 
nanoparticles, the supernatant solutions containing DOX molecules 
were measured by the fluorescence spectrum of DOX (ex = 500 nm). The 
loading capacity of the nanoparticles was determined as the percentage 
of the weight of DOX related to the weight of Pd@Ag@sSiO2@mSiO2-
DihBen-Fe3+ nanoparticles. To study the amount of drug releasing from 
the mesoporous nanoparticles at different pH values, 200 μg of DOX 
loaded nanoparticles were dispersed in 800 μL of PBS buffer at pH values 
of 7.4, 6.0, 5.0, 4.0, and shaken at room temperature. The release media 
solution was collected by centrifugation at a given time for analysis. The 
amount of DOX molecules in the media solution was then measured by 
the fluorescence spectrum, and then calculated the releasing percentage 
of the doxorubicin molecules. To confirm that the drug could controllably 
release from nanoparticles under laser irradiation at low pH value, 
200 μg of DOX loaded nanoparticles were dispersed in 800 μL of PBS 
buffer at pH values of 7.4 and 4.0 separately, and then illuminated by 
laser lamp (λ = 808 nm, 1 W). The release media solution was collected 
at different time for analysis and calculated the released percentage of © 2012 WILEY-VCH Verlag GmAdv. Funct. Mater. 2012, 22, 842–848the doxorubicin molecules. All releasing experiments were repeated 
three times to obtain the releasing curves. The control experiments 
were also carried out under the same procedures only without laser 
irradiation.
Characterization: Transmission electron microscopy (TEM) studies 
were performed on a TECNAI F-30 high resolution transmission electron 
microscope operating at 300 kV. Scanning electron microscopy (SEM) 
images were obtained on Hitachi S4800 scanning electron microscope 
with a field emission electron gun. Surface area and pore size were 
determined by Surface Area and Porosity Analyzer (Micromeritics 
Instrument Corp. ASAP2020).
Cell Culture: Human heatoblastoma cells (Hep-G2) were maintained 
in Duibecco’s modified Eagle’s medium (DMEM) supplemented with 
10% calf serum, 1% penicillin, 1% streptomycin in 37 °C, 5% CO2.
Fluorescence Imaging: Hep-G2 cells were seeded in a 24-well plate and 
cultured for 24 h. The cell medium was removed, and then cells were 
incubated with 0.5 mL of fresh cell medium containing 20 μg of Pd@
Ag@sSiO2@mSiO2-DihBen-Fe3+/DOX nanoparticles for another 4 h. 
Cell imaging was then carried out after washing cells with PBS.
In Vitro Cytotoxicity Assay: For studying the cytotoxicity of the core-
shell mesoporous nanoparticles, Hep-G2 cells were seeded in a 96-well 
plate at a density 104 cells/well for 24 h at 37 °C in 5% CO2. Then, 
the cells were treated with free DOX, Pd@Ag@sSiO2@mSiO2–D 
ihBen-Fe3+/DOX or Pd@Ag@sSiO2@mSiO2-DihBen-Fe3+ nanoparticles 
at desired concentration. After incubation for 10 h, cell viabilities 
were tested by standard MTT (3-(4,5)-dimethylthiahiazo-2-yl)-2,5-
diphenyltetrazolium bromide) assay. To confirm that the nanoparticles 
could efficiently kill cancer cell under laser irradiation, Hep-G2 cells 
were cultured in 96-well plate for 24 h. After that, the medium was 
replaced by 200 μL of cell medium with Pd@Ag@sSiO2@mSiO2-
DihBen-Fe3+/DOX nanoparticles or free DOX at proper concentration. 
After maintained for 8 h, the plates were photo-irradiated by a laser 
lamp (λ = 808 nm, 1 W) for 0 min, 3 min, 5 min. Cell viabilities were 
also tested by standard MTT assay. To identify the cell viability, the dead 
cells were stained with Trypan Blue.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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